164 related articles for article (PubMed ID: 37898670)
1. CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1.
Pfeiffer C; Grandits AM; Asnagli H; Schneller A; Huber J; Zojer N; Schreder M; Parker AE; Bolomsky A; Beer PA; Ludwig H
Leukemia; 2024 Jan; 38(1):181-192. PubMed ID: 37898670
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation.
Minet N; Boschat AC; Lane R; Laughton D; Beer P; Asnagli H; Soudais C; Bourne T; Fischer A; Martin E; Latour S
Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37348953
[TBL] [Abstract][Full Text] [Related]
3. Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.
Durand R; Bellanger C; Kervoëlen C; Tessoulin B; Dousset C; Menoret E; Asnagli H; Parker A; Beer P; Pellat-Deceunynck C; Chiron D
Haematologica; 2024 Feb; ():. PubMed ID: 38385294
[TBL] [Abstract][Full Text] [Related]
4. WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.
Wu X; Kang X; Zhang X; Xie W; Su Y; Liu X; Guo L; Guo E; Li F; Hu D; Qin X; Fu Y; Peng W; Jia J; Wang C
Cancer Sci; 2021 Nov; 112(11):4444-4456. PubMed ID: 34382294
[TBL] [Abstract][Full Text] [Related]
5. A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma.
Xing L; Lin L; Yu T; Li Y; Cho SF; Liu J; Wen K; Hsieh PA; Kinneer K; Munshi N; Anderson KC; Tai YT
Leukemia; 2020 Aug; 34(8):2150-2162. PubMed ID: 32060401
[TBL] [Abstract][Full Text] [Related]
6. CTP Synthase 1 Is a Novel Therapeutic Target in Lymphoma.
Asnagli H; Minet N; Pfeiffer C; Hoeben E; Lane R; Laughton D; Birch L; Jones G; Novak A; Parker AE; Ludwig H; Fischer A; Latour S; Beer PA
Hemasphere; 2023 Apr; 7(4):e864. PubMed ID: 37008165
[TBL] [Abstract][Full Text] [Related]
7. Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells.
Sun Z; Zhang Z; Wang QQ; Liu JL
Cancer Res; 2022 Mar; 82(6):1013-1024. PubMed ID: 35022212
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer.
Nam AR; Jin MH; Bang JH; Oh KS; Seo HR; Oh DY; Bang YJ
Cancer Res Treat; 2020 Jul; 52(3):945-956. PubMed ID: 32311864
[TBL] [Abstract][Full Text] [Related]
9. Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress.
Young LA; O'Connor LO; de Renty C; Veldman-Jones MH; Dorval T; Wilson Z; Jones DR; Lawson D; Odedra R; Maya-Mendoza A; Reimer C; Bartek J; Lau A; O'Connor MJ
Cancer Res; 2019 Jul; 79(14):3762-3775. PubMed ID: 31123088
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival.
Liang JH; Wang C; Yiu SPT; Zhao B; Guo R; Gewurz BE
mBio; 2021 Aug; 12(4):e0153021. PubMed ID: 34281398
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.
Jin MH; Nam AR; Park JE; Bang JH; Bang YJ; Oh DY
Cancer Res Treat; 2020 Jan; 52(1):149-166. PubMed ID: 31291716
[TBL] [Abstract][Full Text] [Related]
12. CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation.
Martin E; Palmic N; Sanquer S; Lenoir C; Hauck F; Mongellaz C; Fabrega S; Nitschké P; Esposti MD; Schwartzentruber J; Taylor N; Majewski J; Jabado N; Wynn RF; Picard C; Fischer A; Arkwright PD; Latour S
Nature; 2014 Jun; 510(7504):288-92. PubMed ID: 24870241
[TBL] [Abstract][Full Text] [Related]
13. Targeting DNA damage response pathways to activate the STING innate immune signaling pathway in human cancer cells.
Wayne J; Brooks T; Landras A; Massey AJ
FEBS J; 2021 Aug; 288(15):4507-4540. PubMed ID: 33529438
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting the ATR-CHK1-WEE1 axis involves balancing cell growth stimulation and apoptosis.
Mak JP; Man WY; Ma HT; Poon RY
Oncotarget; 2014 Nov; 5(21):10546-57. PubMed ID: 25301733
[TBL] [Abstract][Full Text] [Related]
15. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of cytidine triphosphate synthase 1 prevents fatal auto-immunity in mice.
Soudais C; Schaus R; Bachelet C; Minet N; Mouasni S; Garcin C; Souza CL; David P; Cousu C; Asnagli H; Parker A; Palmquist-Gomes P; Sepulveda FE; Storck S; Meilhac SM; Fischer A; Martin E; Latour S
Nat Commun; 2024 Mar; 15(1):1982. PubMed ID: 38438357
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.
Mak JP; Man WY; Chow JP; Ma HT; Poon RY
Oncotarget; 2015 Aug; 6(25):21074-84. PubMed ID: 26025928
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis.
Bukhari AB; Lewis CW; Pearce JJ; Luong D; Chan GK; Gamper AM
J Clin Invest; 2019 Mar; 129(3):1329-1344. PubMed ID: 30645202
[TBL] [Abstract][Full Text] [Related]
19. DNA damage checkpoint kinases in cancer.
Smith HL; Southgate H; Tweddle DA; Curtin NJ
Expert Rev Mol Med; 2020 Jun; 22():e2. PubMed ID: 32508294
[TBL] [Abstract][Full Text] [Related]
20. Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines.
Barbosa RSS; Dantonio PM; Guimarães T; de Oliveira MB; Fook Alves VL; Sandes AF; Fernando RC; Colleoni GWB
Biochem Biophys Res Commun; 2019 Nov; 519(3):597-604. PubMed ID: 31540690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
